Table 4 Antimicrobial susceptibility profiles of LA-SA (n = 86)
Antibiotic Groups | Antibiotic | Conc | Resistant | Intermediate | Sensitive |
|---|---|---|---|---|---|
β-lactams | Ampicillin (AMP) | 10 µg | 42(48.83%) | 0(0.00%) | 44(51.16%) |
| Â | Penicillin (P) | 10 units | 57(66.27%) | 0(0.00%) | 29(33.72%) |
|  | Methicillin (MET) | 5 µg | 26(32.23%) | 0(0.00%) | 60(69.37%) |
|  | Oxacillin (OX) | 1 µg | 12(13.95%) | 23(26.74%) | 41(47.67%) |
Aminoglycosides | Kanamycin (K) | 30 µg | 21(24.41%) | 26(32.23%) | 39(45.34%) |
|  | Streptomycin (S) | 10 µg | 7(8.13%) | 0(0.00%) | 79(91.86%) |
Tetracyclines | Tetracycline (TE) | 25 µg | 28(32.55%) | 21(24.41%) | 37(43.02%) |
|  | Oxytetracycline (O) | 30 µg | 6(6.97%) | 19(20.93%) | 61(70.93%) |
Amphenicols | Chloramphenicol (C) | 25 µg | 19(20.93%) | 0(0.00%) | 68(79.07%) |
Macrolide | Erythromycin (E) | 15 µg | 11(12.79%) | 32(37.20%) | 43(50%) |
Glycopeptides | Vancomycin (VA) | 30 µg | 2(2.32%) | 14(16.27%) | 70(81.39%) |